French morning-after pill wins U.S. approval

By Associated Press
Posted Aug. 13, 2010 at 4:32 p.m.

A French drugmaker says it has won U.S. approval for a new type of morning-after contraceptive that works longer than the leading drug on the market.

The pill Ella from HRA Pharma reduces the chance of pregnancy up to five days after sex. Plan B, the most widely used emergency contraceptive pill, is effective only if women take it within three days of sex.The Food and Drug Administration approved the drug Friday as a prescription-only birth control option. The ruling clears the way for U.S. sales of the drug, which isĀ  approved in Europe.

Ella has drawn criticism from anti-abortion groups who argue the drug is closer to an abortion pill than an emergency contraception pill.

Read more about the topics in this post: , , ,
 

Companies in this article

Comments are closed.